Singapore: Merck, which is known as MSD outside the US and Canada, revealed positive results from its phase Ib study sho...
Singapore: Viralytics has finalized the clinical study report on the phase I evaluation of Cavatak, which is administere...
Singapore: US based Forest Laboratories plans to acquire exclusive rights in the United States for Saphris (asenapine) s...
Singapore: The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's vaccine MenHibrix (meningococcal gr...
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted a second Australian patent f...
Singapore: Vanderbilt University, US, and Bristol-Myers Squibb signed a collaboration agreement for the R&D and comm...
Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food and Drug Administratio...
Singapore: It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year o...
Singapore: A study conducted by Beike Biotechnology Company in conjunction with physicians and researchers at two Chines...
Singapore: Autism results from abnormal cell communication. Testing a new theory, researchers at the University of Calif...
Singapore: Boehringer Ingelheim and the Institute of Molecular Health Science and the Institute of Food, Nutrition and H...
Singapore: A new study by researchers at Columbia University Medical Center, US, revealed that injection of triglyceride...
Singapore: Dicerna Pharmaceuticals, a RNA interference (RNAi) company focused on developing breakthrough oncology thera...
Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open...
Singapore: Bristol-Myers Squibb has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices...
Singapore: Daiichi Sankyo has appointed Dr Glenn Gormley, as president and chairman of Daiichi Sankyo, US. Dr Gormley w...
Singapore: Health Sciences Authority (HSA) in Singapore has approved new treatment, apixaban (Eliquis), marketed by phar...
Singapore: Australia medical biotechnology company, Innate Immunotherapeutics, plans to raise up to $10.93 million (A$12...
